Skip to main content
Premium Trial:

Request an Annual Quote

AM Biotechnologies X-Aptamer Selection Kit

AM Biotechnologies has launched the X-Aptamer Selection Kit for the in-lab discovery of X-Aptamers, next-generation aptamers that feature amino acid and small-molecule functionality attached to DNA bases and selectively bind to antigens with high affinity. The kit features a combinatorial bead-based library employing a single-round process for the discovery of X-Aptamers. The process takes less than a week, including sample preparation, requires no special lab equipment or procedures, and enables the discovery of X-Aptamers for up to five targets in parallel per kit. The introductory price for the kit is $500.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.